Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19

Jasmin D Haslbauer1, Alexandar Tzankov1, Kirsten D Mertz2

  • 1Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in COVID-19 patients is linked to cardiac microvascular injury and coagulopathy. Inflammation was observed in SARS-CoV-2 negative hearts, suggesting a secondary immune response.

Area of Science:

  • Cardiovascular pathology
  • Infectious disease pathology

Background:

  • Coronavirus disease 2019 (COVID-19) primarily impacts the respiratory system, but cardiovascular effects are not fully understood.
  • Autopsy studies are crucial for elucidating the cardiac and vascular pathophysiology of severe COVID-19.

Purpose of the Study:

  • To investigate the cardiopathological changes in COVID-19 patients.
  • To correlate histopathological findings with the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in myocardial tissue.

Main Methods:

  • Retrospective analysis of 23 COVID-19 autopsies, comparing SARS-CoV-2 RNA-positive (n=14) and RNA-negative (n=9) myocardium with 10 controls.
  • Histological scoring of myocardial characteristics, including fibrin deposition, capillary dilatation, microhaemorrhage, and inflammatory infiltrate.
  • In situ hybridization (ISH) performed on five RT-PCR-positive cases to detect viral RNA in interstitial cells.

Main Results:

  • Patients with SARS-CoV-2 positive myocardium had shorter hospital stays (5 days) compared to RNA-negative cases (12 days).
  • Increased fibrin deposition, capillary dilatation, and microhaemorrhage were significantly higher in SARS-CoV-2 positive myocardium, correlating with COVID-19-associated coagulopathy.
  • Cardioinflammation, including myocarditis, was observed only in SARS-CoV-2 RNA-negative hearts, suggesting a potential secondary immunological response.

Conclusions:

  • Myocardial capillary dilatation, fibrin deposition, and microhaemorrhage are histomorphological indicators of COVID-19-associated coagulopathy.
  • The presence of inflammation in SARS-CoV-2 negative hearts suggests a delayed or secondary immune response in lethal COVID-19.
  • Further research is warranted to characterize the immunological mechanisms driving cardiac pathology in COVID-19 patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
155
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
122
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.0K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
135
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
185